Biomea Fusion, Inc. - Common Stock (NQ:BMEA)

1.320 +0.070 (+5.60%)

Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biomea Fusion, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Biomea Fusion Presents Positive Clinical Data from the Initial Cohorts of the Ongoing Phase II Study (COVALENT-111) of BMF-219 in Patients with Type 2 Diabetes Mellitus at the American Diabetes Association (ADA) 83rd Scientific Sessions; 100 mg Cohort 3

June 23, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes at ADA 2023

June 20, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Analyst Ratings for Biomea Fusion ↗

May 18, 2023

Via Benzinga

Recap: Biomea Fusion Q1 Earnings ↗

May 02, 2023

Via Benzinga

Analyst Ratings for Biomea Fusion ↗

April 19, 2023

Via Benzinga

Why Biomea Fusion Stock Crushed It This Week ↗

March 30, 2023

A promising data readout in type 2 diabetes lit a fire underneath the biotech's stock this week.

Via The Motley Fool

Where Biomea Fusion Stands With Analysts ↗

March 28, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2023 ↗

May 12, 2023

Via Benzinga

Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights

May 02, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Announces FDA Clearance of Investigational New Drug (IND) Application for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia

May 01, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion to Present Late Breaking Data from Ongoing Phase II Trial, COVALENT-111, Evaluating BMF-219 in Patients with Type 2 Diabetes, at the ADA 83rd Scientific Sessions 2023 in June

April 19, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion To Present Two Preclinical Posters at the 114th AACR Annual Meeting

April 13, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

April 13, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

These 5 High-Growth Small-Cap Stocks Surged More Than 100% In Q1: What's Next? ↗

April 05, 2023

The S&P 500 index, which is tracked by the SPDR S&P 500 ETF Trust (ARCA: SPY), posted a gain of 6.2% in the first quarter of 2023, while technology stocks in the Nasdaq 100 index, which is tracked by...

Via Benzinga

$12M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

April 04, 2023

Although US stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

Biomea Fusion Announces Pricing of Upsized Public Offering of Common Stock

March 29, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Is Cathie Wood Giving Up on Xpeng (XPEV) Stock? ↗

March 29, 2023

Investors in Xpeng (XPEV) are wondering if Cathie Wood is giving up on the stock after a recent selloff during a strong rally.

Via InvestorPlace

What's Going On With Biomea Fusion Stock? ↗

March 29, 2023

Biomea Fusion Inc (NASDAQ: BMEA) shares are trading higher. The company reported fourth-quarter results after the bell and announced an offering Wednesday morning. Several analysts are out with...

Via Benzinga

Dear SBNY Stock Fans, Mark Your Calendars for April 5 ↗

March 29, 2023

Fans of Signature Bank (SBNY) stock will want to keep an eye on the financial company for a catalyst when April 5 rolls around.

Via InvestorPlace

BMEA Stock: Biomea Fusion Pops on Public Offering News ↗

March 29, 2023

Biomea Fusion (BMEA) stock is climbing higher on Wednesday after the company announced a public offering plan and continues a recent rally.

Via InvestorPlace

Biomea Fusion Announces Proposed Public Offering of Common Stock

March 29, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Highlights

March 28, 2023

From Biomea Fusion, Inc.

Via GlobeNewswire

Nasdaq Dips 90 Points; Walgreens Posts Upbeat Q2 Results ↗

March 28, 2023

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 90 points on Tuesday. The Dow traded down 0.21% to 32,362.74 while the NASDAQ fell 0.77% to 11,678.39. The...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

March 28, 2023

Via Benzinga

Why Alibaba Shares Are Trading Higher By Over 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 28, 2023

Gainers

Via Benzinga

Stocks Mixed After Upbeat Consumer Confidence Data ↗

March 28, 2023

The Dow Jones Industrial Average managed to swing into positive territory this afternoon, though the S&P 500 Index and Nasdaq Composite Index are still sitting in the red.

Via Talk Markets

Dow Rises 50 Points; Harmony Biosciences Shares Plunge ↗

March 28, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 50 points on Tuesday. The Dow traded up 0.16% to 32,484.24 while the NASDAQ fell 0.75% to 11,681.12. The S&P 500, also...

Via Benzinga

Biomea Fusion (NASDAQ: BMEA) Reports Positive Initial Findings From the COVALENT-111 Phase II Study of BMF-219 for the Treatment of Type 2 Diabetes

March 28, 2023

Biomea Fusion, Inc. (NASDAQ: BMEA) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research, discovery and

Via Spotlight Growth

What's Driving Biomea Fusion Shares Higher Today? ↗

March 28, 2023

Biomea Fusion Inc (NASDAQ: BMEA) shares are trading higher Tuesday after the company announced data from the initial cohorts of the ongoing Phase II study of BMF-219 in patients with

Via Benzinga

Nasdaq Down Over 50 Points; US Goods Trade Deficit Widens Slightly ↗

March 28, 2023

U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.01% to 32,436.22 while the NASDAQ fell...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.